Exercise and mitochondrial health are directly linked. Physical activity is one of the most effective strategies for supporting long-term metabolic, neurological, and cardiovascular function because it enhances mitochondrial performance across multiple tissues. Mitochondria are the organelles responsible for generating ATP, regulating oxidative metabolism, and maintaining cellular energy balance. In conditions such as depression, diabetes, hypertension, atherosclerosis, Parkinson’s disease, Alzheimer’s disease, ALS, and multiple sclerosis, mitochondrial dysfunction is consistently associated with impaired cellular resilience, oxidative stress, inflammation, and reduced energy production.
Regular exercise activates endogenous signaling pathways that stimulate mitochondrial biogenesis, improve oxidative phosphorylation efficiency, and promote removal of dysfunctional mitochondria through mitophagy. These adaptations support neuronal connectivity, endothelial function, insulin sensitivity, vascular flexibility, and cellular stress resistance. Exercise also enhances brain-derived neurotrophic factor (BDNF) signaling and neuroplasticity, supporting cognitive performance, mood regulation, and nervous-system resilience. The resulting improvements in mitochondrial efficiency extend across multiple organ systems and contribute to better cardiovascular performance, metabolic balance, motor coordination, and cognitive function. Rather than acting through a single pathway, exercise engages broad biological networks that influence cellular energetics, redox homeostasis, inflammation, and neurotrophic support.
The Central Role of Mitochondrial Bioenergetics in the Biological Effects of Exercise
Traditional models of mood disorder pathophysiology have long emphasized monoaminergic imbalances, particularly serotonin signaling deficits, as a major neurochemical driver of major depressive disorder (MDD). However, a growing body of biochemical and cellular evidence positions mitochondrial dysfunction as a more proximal and integrative biological node. Impaired oxidative phosphorylation (OXPHOS), reduced ATP availability, elevated mitochondrial reactive oxygen species (mtROS), disrupted mitochondrial dynamics (excessive fission via Drp1 upregulation with suppressed fusion proteins Mfn1/2 and OPA1), defective mitophagy (PINK1/Parkin pathway hypoactivity), and downregulated biogenesis regulators (PGC-1α, NRF1/2, TFAM) collectively produce an energy deficit that compromises neuronal membrane potential, synaptic vesicle cycling, dendritic arborization, and adult hippocampal neurogenesis.
These bioenergetic disruptions manifest as fatigue, anhedonia, reduced motivation, impaired cognition, and diminished stress resilience while simultaneously amplifying neuroinflammation through NLRP3 inflammasome activation and cytokine release that further impair electron transport chain (ETC) complexes I and IV. In contrast to the serotonin-centric framework, mitochondrial impairments are reproducibly documented in post-mortem prefrontal and hippocampal tissue, peripheral blood mononuclear cells (PBMCs), platelets, and fibroblasts from MDD patients, as well as in chronic stress rodent models.
Exercise intervenes directly at this mitochondrial nexus through coordinated molecular cascades that restore cellular energetics and downstream plasticity, offering a mechanistically distinct and complementary biological strategy.
PGC-1α: The Master Regulator of Exercise-Induced Mitochondrial Adaptation
The master regulator of exercise-induced mitochondrial adaptation is peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). Skeletal muscle contraction elevates the AMP/ATP ratio, activating AMP-activated protein kinase (AMPK), which phosphorylates PGC-1α while SIRT1-mediated deacetylation further enhances its transcriptional co-activator function.
PGC-1α then activates nuclear respiratory factors NRF1 and NRF2, which upregulate mitochondrial transcription factor A (TFAM) to initiate mitochondrial DNA replication and transcription of ETC subunit genes. This biogenesis program increases mitochondrial mass, spare respiratory capacity, and ATP-linked oxygen consumption while simultaneously elevating antioxidant enzymes such as SOD2 and glutathione peroxidase to reduce mtROS accumulation.
In parallel, muscle PGC-1α induces fibronectin type III domain-containing protein 5 (FNDC5), whose cleavage product irisin crosses the blood-brain barrier and engages neuronal integrin αVβ5 receptors. Irisin activates ERK1/2 and CREB phosphorylation cascades that directly stimulate BDNF transcription. BDNF-TrkB signaling subsequently activates mTORC1, PI3K/Akt, and MAPK pathways that promote dendritic spine maturation, long-term potentiation (LTP), and dentate gyrus progenitor proliferation.
Lactate generated during muscle glycolysis provides an additional signaling mechanism by activating the G-protein-coupled receptor HCAR1 on neurons, stimulating SIRT1/PGC-1α activity and reinforcing BDNF expression.
Animal studies in chronic stress models demonstrate that voluntary wheel running or treadmill protocols reverse hippocampal mitochondrial fragmentation, restore Complex I and IV activity, normalize ATP levels, and reverse depressive-like behavioral phenotypes. These effects are significantly reduced by PGC-1α knockdown or irisin-neutralizing antibodies. Human investigations using PBMC or platelet respirometry show that structured exercise programs elevate mitochondrial respiratory parameters and mtDNA copy number while correlating with reductions in depression severity scores independent of peripheral serotonin metabolite changes.
Secondary Convergent Mechanisms Supporting Mitochondrial Function
Exercise amplifies mitochondrial and neurotrophic adaptations through several additional pathways that converge on the PGC-1α/BDNF axis.
Kynurenine Pathway Modulation
Muscle PGC-1α upregulates kynurenine aminotransferases (KATs), diverting tryptophan-derived kynurenine into the neuroprotective metabolite kynurenic acid (KYNA) rather than the neurotoxic quinolinic acid (QA). Reduced QA limits NMDA receptor overactivation and associated oxidative stress, thereby preserving mitochondrial integrity and synaptic stability.
Anti-Inflammatory Actions
Acute exercise releases IL-6 as a myokine that suppresses pro-inflammatory TNF-α and IL-1β, while chronic training downregulates microglial NF-κB and NLRP3 inflammasome activity. This indirectly supports mitochondrial function because inflammatory cytokines otherwise impair ETC complexes and promote mtDNA damage.
HPA Axis Regulation
Improved glucocorticoid receptor sensitivity reduces chronic cortisol exposure, preventing glucocorticoid-mediated repression of PGC-1α transcription and helping maintain mitochondrial adaptation under stress.
Epigenetic Reinforcement
Exercise induces histone deacetylase (HDAC) inhibition and promoter demethylation at BDNF exon IV, amplifying BDNF expression and sustaining long-term neuroplasticity and mitochondrial remodeling.
Exercise, Mitochondria and Type 2 Diabetes
In type 2 diabetes, skeletal muscle mitochondrial dysfunction contributes to insulin resistance by impairing GLUT4 translocation and fatty-acid oxidation. Exercise-induced AMPK/PGC-1α activation upregulates TFAM and ETC components, enhancing β-oxidation and restoring NAD+/NADH ratios that facilitate SIRT1-dependent deacetylation of PGC-1α and FOXO1.
These changes improve insulin signaling through IRS-1 tyrosine phosphorylation and Akt activation. Rodent high-fat-diet and db/db models demonstrate restored muscle oxygen consumption rates, reduced intramuscular lipid accumulation, and normalized fasting glucose after chronic exercise interventions. Human randomized trials similarly report improved mitochondrial enzyme activity and insulin sensitivity preceding measurable HbA1c reductions.
Exercise, Endothelial Mitochondria and Hypertension
In hypertension, endothelial mitochondrial ROS excess reduces nitric oxide (NO) bioavailability through peroxynitrite formation, promoting vasoconstriction and vascular stiffness. Exercise restores endothelial PGC-1α signaling, which transcriptionally induces eNOS while suppressing NADPH oxidase subunits.
The resulting increase in NO bioavailability improves vascular relaxation and endothelial responsiveness. Studies in spontaneously hypertensive rats show normalized aortic mitochondrial membrane potential and reduced superoxide production after exercise, accompanied by lower systolic blood pressure. Human cohorts demonstrate similar improvements in flow-mediated dilation and ambulatory blood pressure following aerobic training.
Atherosclerosis and Vascular Mitochondrial Dysfunction
Atherosclerosis progression is strongly influenced by mitochondrial oxidative stress within endothelial cells and plaque macrophages. This stress activates NF-κB signaling and promotes foam-cell formation through oxidized LDL uptake.
Exercise-induced PGC-1α signaling in endothelial and smooth-muscle cells enhances antioxidant defenses and mitophagy while limiting mtDNA damage and NLRP3-driven IL-1β release. Muscle-derived irisin additionally suppresses vascular smooth-muscle proliferation through Akt/ERK modulation.
ApoE−/− mouse models demonstrate reduced plaque burden, lower oxidized LDL accumulation, and more stable fibrous caps following exercise protocols. Human imaging studies similarly show slower intima-media thickness progression and improved coronary flow reserve in physically active individuals.
Parkinson’s Disease and Mitochondrial Restoration
In Parkinson’s disease, dopaminergic neurons of the substantia nigra exhibit Complex I deficiency, α-synuclein-associated mitochondrial disruption, and defective PINK1/Parkin-mediated mitophagy.
Exercise activates PGC-1α in both muscle and nigrostriatal neurons, increasing TFAM expression and ETC subunit synthesis while improving Parkin recruitment to damaged mitochondria. These adaptations support dopamine synthesis pathways and improve mitochondrial respiration.
Rodent MPTP and 6-OHDA models show preservation of tyrosine hydroxylase-positive neurons, reduced α-synuclein aggregation, normalized mitochondrial function, and improved motor performance following treadmill or wheel-running interventions. Human observational studies associate higher cardiorespiratory fitness with slower progression of Parkinsonian functional decline.
Alzheimer’s Disease and Brain Energy Metabolism
In Alzheimer’s disease, amyloid-β and hyperphosphorylated tau disrupt mitochondrial transport, inhibit Complex IV, and promote excessive mitochondrial fission via Drp1 activation.
Exercise-induced PGC-1α and BDNF signaling promote mitophagy and reduce amyloidogenic processing through enhanced α-secretase activity. APP/PS1 transgenic mice demonstrate reduced plaque burden, restored hippocampal ATP production, normalized mitochondrial dynamics, and improved spatial memory following chronic running protocols.
Human studies show elevated CSF BDNF levels, reduced neurofilament light chain concentrations, and enhanced hippocampal activation during memory tasks in physically active individuals.
ALS, Multiple Sclerosis and Mitochondrial Resilience
ALS is characterized by mitochondrial fragmentation, ETC inhibition, calcium dysregulation, and oxidative stress within motor neurons. Exercise upregulates PGC-1α and antioxidant systems while improving mitochondrial calcium buffering.
SOD1-G93A mouse models display delayed disease onset, preserved neuromuscular junction integrity, improved mitochondrial membrane potential, and extended survival following moderate treadmill activity.
In multiple sclerosis, demyelination produces axonal mitochondrial redistribution and energy imbalance. Exercise stimulates oligodendrocyte precursor PGC-1α signaling, supporting remyelination and reducing axonal mtROS accumulation.
Experimental autoimmune encephalomyelitis (EAE) models demonstrate preserved mitochondrial cristae structure, improved Complex I activity, and reduced demyelination following exercise. Human MS cohorts similarly show enhanced mitochondrial respiratory capacity, reduced fatigue, and more stable disability scores among physically active individuals.
Exercise as a Physiological Regulator of Mitochondrial Function
Exercise functions as a powerful physiological regulator of mitochondrial health. Through activation of AMPK/PGC-1α signaling and secondary convergent pathways—including kynurenine metabolism shifts, anti-inflammatory signaling, HPA-axis normalization, and epigenetic reinforcement—it restores the bioenergetic foundation that underlies neuronal, metabolic, and vascular resilience.
These mechanisms extend far beyond mood regulation alone and influence mitochondrial quality control, redox balance, neuroplasticity, insulin sensitivity, endothelial function, and tissue adaptability across multiple organ systems. The convergence of mitochondrial biogenesis, antioxidant defense, and neurotrophic signaling provides a unified biological framework explaining the broad systemic effects of physical activity on long-term health and aging.
References
[1] Liu Y et al. The Role of Mitochondrial Energy Metabolism in Depression and the Biological Effects of Exercise. 2025.
[2] Ramos-Jiménez A et al. Adaptations in Mitochondrial Function Induced by Exercise. Int J Mol Sci. 2025.
[3] Bi X et al. The interplay between BDNF and PGC-1 alpha in maintaining brain health. Front Endocrinol. 2024.
[4] Song Y et al. Mitochondrial dysfunction: A central mechanism in depression. Biomed Pharmacother. 2023.
[5] Cefis M et al. Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction. Front Mol Neurosci. 2023.
[6] Jo D et al. Irisin Acts via the PGC-1α and BDNF Pathway to Support Mood and Brain Function. 2021.
[7] Zong Y et al. Mitochondrial dysfunction: mechanisms and advances in biological intervention strategies. Signal Transduct Target Ther. 2024.
[8] Additional mechanistic and translational studies on PGC-1α, irisin, and mitochondrial dynamics in PD, AD, ALS, and MS models (2023–2025).
Related Mitochondrial & Exercise-Mimetic Research Compounds
Researchers investigating mitochondrial function, cellular energy metabolism, exercise-mimetic signaling, oxidative stress regulation, and metabolic resilience often explore the following compounds:
- SLU-PP-332 Capsules – experimental ERR agonist researched for exercise-mimetic signaling, mitochondrial biogenesis, and oxidative metabolism.
- SLU-PP-332 Vial – research format investigated for ERR activation, fatty-acid oxidation, and mitochondrial transcriptional pathways.
- SLU-PP-915 – orally active pan-ERR agonist investigated for mitochondrial function, fatty-acid oxidation, and cellular energy metabolism.
- O-304 – AMPK-related research compound studied for metabolic flexibility and mitochondrial efficiency.
- MOTS-c – mitochondrial-derived peptide researched for exercise adaptation and metabolic stress signaling pathways.
- SS-31 – mitochondria-targeted peptide investigated for cardiolipin stabilization, mitochondrial respiration, and oxidative stress modulation.
- 1-MNA – nicotinamide metabolite researched for endothelial signaling, mitochondrial metabolism, and vascular function.
- NAD+ – metabolic cofactor involved in mitochondrial respiration, redox balance, and cellular energy production.
- Glutathione – intracellular antioxidant researched for mitochondrial redox homeostasis and oxidative stress regulation.
- 5-Amino-1MQ – research compound studied for metabolic regulation and cellular energy utilization pathways.